Neurology
Top Medical News
_1_2_Square.png)
3 hours ago
Babies who weigh ≥8.5 kg can safely be administered with onasemnogene abeparvovec for the treatment of spinal muscular atrophy, a new study has found.

Jairia Dela Cruz,
7 hours ago
Eating a small cup of cranberries daily is apparently good for the brain, enhancing memory consolidation and retrieval for everyday events as well as neural functioning in healthy older adults, as shown in a recent study.

Jairia Dela Cruz,
Yesterday
Following nonvalvular atrial fibrillation (NVAF)-associated stroke events, a graded increase in delay in direct oral anticoagulants (DOACs) initiation of between 1 and 4 days, depending on the severity of the index event, appears to be effective for recurrent stroke prevention and does not compromise safety both in Asians and Europeans, according to a recent study.

Elvira Manzano,
Yesterday
A diet rich in fat but low in carbohydrates, popularly known as the ketogenic or “keto” diet, offers clinical benefits to patients with relapsing multiple sclerosis (MS) in a phase II study. Quality of life (QoL) likewise improved, and so did disability.

2 days ago
Subjective cognitive decline appears to be indicative of stage 2 Alzheimer’s disease, where individuals exhibit mild changes in mood or behaviour and subtle objective cognitive decline although not to the point of meeting mild cognitive impairment criteria, as suggested in a study.

4 days ago
Patients who have had a stroke despite being on nonvitamin K antagonist oral anticoagulant therapy are likely to experience a recurrent ischaemic stroke episode and bleeding, according to data from the RENO-EXTEND Study.
Special Reports


04 May 2018
Multiple sclerosis (MS) is one of the most common neurological disorders – affecting over 2.3 million people globally – and it is the leading cause of nontraumatic disability in young adults. However,the availability of supportive resources and services for people with MS is scarce in many regions of the world. In Malaysia, the prevalence of MS is estimated at 2-3/100,000; the current Malaysian clinical practice guidelines on the management of MS recommend disease modifying agents, such as interferon-β and teriflunomide, as first-line therapeutic agents. In this article, Dr Singer - in partnership with Sanofi and the Malaysian Society of Neurosciences - shares his insights into managing MS dynamically, highlighting the importance of early intervention in improving patient outcomes.
Conference Reports

Elvira Manzano,
23 May 2022
A diet rich in fat but low in carbohydrates, popularly known as the ketogenic or “keto” diet, offers clinical benefits to patients with relapsing multiple sclerosis (MS) in a phase II study. Quality of life (QoL) likewise improved, and so did disability.

Roshini Claire Anthony,
19 May 2022
Patients with relapsing-remitting multiple sclerosis (RRMS) who have suboptimal response to disease-modifying therapies (DMTs) experienced low disease activity after switching to ocrelizumab, according to interim results of the LIBERTO study.

Elaine Soliven,
19 May 2022
Patients with Parkinson’s disease dementia (PDD) who continued treatment with pimavanserin had a lower risk of psychosis relapse compared with those on placebo, according to a post hoc analysis of the HARMONY* trial presented at AAN 2022.

Roshini Claire Anthony,
13 May 2022
Several studies presented at AAN 2022 have revealed a lack of association between COVID-19 vaccination and negative cerebrovascular outcomes.

Audrey Abella,
10 May 2022
Intravenous (IV) edaravone seems to continue to provide hope for individuals with amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease with no known cure, according to data presented at AAN 2022.

Pearl Toh,
09 May 2022
Treatment with ravulizumab leads to rapid and sustained reductions in myasthenia gravis (MG) symptoms, according to the CHAMPION study presented at AAN 2022.

Audrey Abella,
05 May 2022
Lower-sodium oxybate – a new oxybate treatment with 92-percent less sodium than sodium oxybate – continued to demonstrate its potential in improving function, productivity, and sleepiness in individuals with idiopathic hypersomnia, according to data presented at AAN 2022.